Larry Robbins’s Glenview Capital Management: Tenet Healthcare Corp Position increased

Tenet Healthcare Corporation (NYSE:THC) Logo

Investors sentiment decreased to 0.87 in Q1 2019. Its down 0.42, from 1.29 in 2018Q4. It is negative, as 31 investors sold Tenet Healthcare Corporation shares while 77 reduced holdings. 36 funds opened positions while 58 raised stakes. 99.78 million shares or 2.80% less from 102.65 million shares in 2018Q4 were reported.

Thrivent Fincl For Lutherans has 0% invested in Tenet Healthcare Corporation (NYSE:THC). Ohio-based Employees Retirement Of Ohio has invested 0.02% in Tenet Healthcare Corporation (NYSE:THC). Carroll Assoc invested in 0% or 101 shares. Massachusetts Service Ma has 104,230 shares. Fincl Bank Of America De invested in 0% or 420,505 shares. New York State Common Retirement Fund invested 0% in Tenet Healthcare Corporation (NYSE:THC). Creative Planning accumulated 31,544 shares or 0% of the stock. Rafferty Asset Mngmt Ltd Liability, a New York-based fund reported 18,450 shares. Comerica Retail Bank has 53,460 shares. Gemmer Asset Mngmt Ltd Llc, California-based fund reported 79 shares. 385,881 were accumulated by Principal Fincl. 121,823 are held by Endurant Capital Mgmt L P. Employees Retirement Of Texas reported 29,000 shares. Ontario Teachers Pension Plan Board holds 0.01% or 12,070 shares. Rhumbline Advisers holds 246,680 shares or 0.01% of its portfolio.

Since July 24, 2019, it had 1 buy, and 0 insider sales for $16.23 million activity.

Larry Robbins’s Glenview Capital Management Reported increased Stake in Tenet Healthcare Corp

Glenview Capital Management filed with SEC a SC 13D/A form for Tenet Healthcare Corp. It can be found at: 000090514819000803. As reported by Larry Robbins’s Glenview Capital Management, the filler increased its stake in the stock by 7.44 % for 19,383,829 shares. Larry Robbins’s Glenview Capital Management currently owns 18.73% of the Health Care- stock. Date of activity: August 14, 2019.

The hedge fund with about $13.95 billion looks more positive after reporting such an increase of its Tenet Healthcare Corp ownership.

The hedge fund is investor in the Health Care sector.

Tenet Healthcare Corp Institutional Sentiment

Filings show 191 investors own Tenet Healthcare Corp. The ownership in Q3 2017 is high, at Infinity of the outstanding shares. This is increased by 9726388. 122378344 were owned by these investors. 41 funds opened new Tenet Healthcare Corp stakes, 79 increased positions. There were 33 that closed positions and 57 reduced them.

7 investors had the stock in their top 10. Some are: Nantahala Capital Management Llc, Davidson Kempner Capital Management Lp, Phoenix Investment Adviser Llc, Cyrus Capital Partners L.P., Glenview Capital Management Llc, Redwood Capital Management Llc..

Conan Laughlin North Tide Capital Llc is an investor bullish on Tenet Healthcare Corp, owning 1534200 shares as of Q3 2017 for 5.38% of its portfolio. Brian J. Higgins King Street Capital Management Lp owns 1900000 shares or 3.91% of its portfolio. MA Camber Capital Management Llc have 5.99% of its portfolio for 5750000 shares. Further, Caspian Capital Lp reported stake worth 11.05% of its portfolio. The OH Winslow Asset Management Inc owns 254247 shares. Tenet Healthcare Corp is 0.81% of its portfolio.

SEC Form 13D.

The stock decreased 2.91% or $0.57 during the last trading session, reaching $18.99. About 1.01 million shares traded. Tenet Healthcare Corporation (NYSE:THC) has declined 37.03% since August 15, 2018 and is downtrending. It has underperformed by 37.03% the S&P500.

Tenet Healthcare Corporation, together with its subsidiaries, operates as a diversified healthcare services company. The company has market cap of $1.96 billion. It operates in three divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. It currently has negative earnings. The company's general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Tenet Healthcare Corporation (NYSE:THC) Ratings Coverage

Among 8 analysts covering Tenet Healthcare (NYSE:THC), 1 have Buy rating, 0 Sell and 7 Hold. Therefore 13% are positive. Tenet Healthcare has $37 highest and $26 lowest target. $29.88’s average target is 57.35% above currents $18.99 stock price. Tenet Healthcare had 13 analyst reports since February 25, 2019 according to SRatingsIntel. The stock of Tenet Healthcare Corporation (NYSE:THC) earned “Buy” rating by Citigroup on Wednesday, February 27. Barclays Capital maintained it with “Hold” rating and $26 target in Wednesday, February 27 report. SunTrust maintained the stock with “Hold” rating in Wednesday, February 27 report. The stock of Tenet Healthcare Corporation (NYSE:THC) earned “Hold” rating by RBC Capital Markets on Tuesday, February 26. Bank of America maintained Tenet Healthcare Corporation (NYSE:THC) rating on Tuesday, February 26. Bank of America has “Hold” rating and $30 target. The rating was maintained by Goldman Sachs with “Neutral” on Wednesday, August 14. Robert W. Baird maintained it with “Hold” rating and $30 target in Monday, February 25 report. Stephens maintained the stock with “Hold” rating in Tuesday, February 26 report.

More notable recent Tenet Healthcare Corporation (NYSE:THC) news were published by: which released: “Canopy Growth’s U.S. Cannabis Strategy Will Pay Off – Seeking Alpha” on August 01, 2019, also with their article: “The Best Marijuana Stocks in the First Half of 2019 – Yahoo Finance” published on July 01, 2019, published: “The Week In Cannabis: A New Global Leader, Moves In UK And Colombia, ETFs Outperform – Yahoo Finance” on July 21, 2019. More interesting news about Tenet Healthcare Corporation (NYSE:THC) were released by: and their article: “Tenet extends partnership with Cerner – Seeking Alpha” published on February 07, 2019 as well as‘s news article titled: “Tenet and Aetna Sign Multi-Year Agreement – Business Wire” with publication date: June 24, 2019.

Tenet Healthcare Corporation (NYSE:THC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.